PMI/Private Medical Insurance

William Russell Global Health, Life and Income Protection insurance plans are now available in Abu Dhabi.

Two more cancer drugs have been provisionally banned for NHS after it was decided they were too expensive for the potential results.

The Association of Medical Insurance Intermediaries (AMII) has secured chair of the Health Select Committee, Stephen Dorrell MP as key speaker at its private healthcare summit.

Given the Financial Ombudsman Service's (FOS) desire to see larger caseload contributors paying a greater share of the costs, do you think this heralds a focus on smaller companies well being from regulators?

Jelf has warned that many of the key recommendations of the Sickness Absence Review are unlikely to ever be realised and called its decision to ignore income protection (IP) as ‘madness'.

InterGlobal is to sponsor the International Air Ambulance Alliance (IAAA), a network committed to raising the professional standards of fixed-wing air ambulance providers.

The news that the ABI and British Medical Association (BMA) agreement on GP report (GPR) fees has broken down will usher in a period of uncertainty.

The British Medical Association (BMA) has called for the Office of Fair Trading (OFT) to extend its private healthcare market review to include insurers' fee schedules.

Medical insurance brokers have branded Defacto's new private medical insurance (PMI) star ratings as ‘highly dangerous and not in the best interest of customers'.

Axa PPP has extended its cancer coverage to include the clinically effective prostate cancer drug rejected for the NHS because it is too expensive.